Table of contents

Research papers

• Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study (21 September, 2009)

  Uwe Ehrt, Karl Broich, Jan Petter Larsen, Clive Ballard, Dag Aarsland
• Longitudinally extensive myelopathy in Caucasians: a West Australian study of 26 cases from the Perth Demyelinating Diseases Database (25 August, 2009)

  W Qiu, J-S Wu, M-N Zhang, T Matsushita, J-i Kira, W M Carroll, F L Mastaglia, A G Kermode
• Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes (10 September, 2009)

  M Di Filippo, V M Anderson, D R Altmann, J K Swanton, G T Plant, A J Thompson, D H Miller
• Blood–brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis (25 August, 2009)

  R Topakian, T R Barrick, F A Howe, H S Markus
• MR diffusion and perfusion parameters: relationship to metabolites in acute ischaemic stroke (16 August, 2009)

  Vera Cvoro, Ian Marshall, Paul A Armitage, Mark E Bastin, Trevor Carpenter, Carly S Rivers, Martin S Dennis, Joanna M Wardlaw
• Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations

  (15 September, 2009)

  Bing Wen, Tingjun Dai, Wei Li, Yuying Zhao, Shuping Liu, Chunhua Zhang, Honghao Li, Jinling Wu, Danian Li, Chuanzhu Yan
• The Rehabilitation Complexity Scale version 2: a clinimetric evaluation in patients with severe complex neurodisability (8 July, 2009)

  Lynne Turner-Stokes, Heather Williams, Richard J Siegert
• Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders? (30 September, 2009)

  Stéphanie Cantiniaux, Marianne Vaugoyeau, Danièle Robert, Christine Horrelou-Pitek, Julien Mancini, Tatiana Witjas, Jean-Philippe Azulay
• Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies (2 September, 2009)

  Alessandro F Fois, Clare J Wotton, David Yeates, Martin R Turner, Michael J Goldacre
• Upregulation of persistent sodium conductances in familial ALS (2 September, 2009)

  Steve Vucic, Matthew C Kiernan
• Standardised measurement of self-awareness deficits in FTD and AD (9 February, 2009)

  Craig Williamson, Oscar Alcantar, Johannes Rothlind, Deborah Cahn-Weiner, Bruce L Miller, Howard J Rosen
• The impact of lesion location and lesion size on poststroke infection frequency (2 September, 2009)

  Jens Minnerup, Heike Wersching, Benjamin Brokinkel, Rainer Dziewas, Peter Ulrich Heuschmann, Darius Günther Nabavi, Erich Bernd Ringelstein, Wolf-Rüdiger Schäbitz, Martin Andreas Ritter
• Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India

  (3 September, 2009)

  Monika Vinish, Sudesh Prabhakar, Madhu Khullar, Indu Verma, Akshay Anand
• The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson's disease (2 September, 2009)

  Cris Zampieri, Arash Salarian, Patricia Carlson-Kuhta, Kamiar Aminian, John G Nutt, Fay B Horak